The integration of chemotherapy and surgery for bladder cancer

Matthew D. Galsky, Harry W. Herr, Dean F. Bajorin

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Despite surgery with curative intent, approximately 50% of patients with muscle-invasive transitional cell carcinoma of the bladder will develop distant metastases and succumb to their disease. Attempts to improve outcomes have focused on refining surgical techniques and integrating perioperative chemotherapy. This review summarizes the available literature addressing the role of pelvic lymph-adenectomy, neoadjuvant chemotherapy, and adjuvant chemotherapy in the management of patients with muscle-invasive transitional cell carcinoma of bladder.

Original languageEnglish
Pages (from-to)45-51
Number of pages7
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume3
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

Keywords

  • Adjuvant chemotherapy
  • Bladder cancer
  • Lymphadenectomy
  • Neoadjuvant chemotherapy

Fingerprint

Dive into the research topics of 'The integration of chemotherapy and surgery for bladder cancer'. Together they form a unique fingerprint.

Cite this